DR info

臨床試験数 : 18 / 薬物数 : 26 - (DrugBank : 14) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 45

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

AS
   Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
      2020   -   ChiCTR2000033234   China;
B-lines SE
   Fatebenefratelli Hospital
      2016   -   NCT03049995   Italy;
CPX
   Klinik für Kardiologie, Pneumologie und Angiologie
      2018   -   NCT03835494   Germany;
Calcium gluconate
   National Center for Research Resources (NCRR)
      1995   -   NCT00004361   -
Cardiac MRI
   Bernhard Kuhn
      2022   Phase 1   NCT04713657   United States;
Cellvizio 100 Series System with Confocal Miniprobes
   Aditya Kaza
      2019   Phase 2   NCT04017975   United States;
Coenzyme Q10
   Fuwai Central China Cardiovascualr Hospital
      2019   Phase 0   ChiCTR1900025513   China;
Cold Cadioplegia
   Ain Shams University
      2021   Early Phase 1   NCT05176782   Egypt;
Coronary flow reserve SE
   Fatebenefratelli Hospital
      2016   -   NCT03049995   Italy;
Dexmedetomidine
   Athena Zuppa
      2004   Phase 1   NCT00573066   -
   HealthCore-NERI
      2014   Phase 1   NCT01915277   United States;
   Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University
      2016   -   ChiCTR-IOR-16008571   China;
Diastolic function SE
   Fatebenefratelli Hospital
      2016   -   NCT03049995   Italy;
Dobutamin
   Competence Network for Congenital Heart Defects
      2007   Phase 3   NCT00564993   Germany;
Dobutamine
   Deutsche Herzzentrum Berlin, Kompetenznetz Angeborene Herzfehler
      2007   -   EUCTR2007-003461-41-DE   Germany;
   University Hospital Tuebingen
      2007   -   NCT00557934   Germany;
Echocardiogram
   Bernhard Kuhn
      2022   Phase 1   NCT04713657   United States;
Eplerenone
   Washington University School of Medicine
      2013   Phase 4   NCT01971593   United States;
Fentanyl (High Dose)
   Nationwide Children's Hospital
      2008   Phase 2   NCT00848393   United States;
Fentanyl (Low Dose)
   Nationwide Children's Hospital
      2008   Phase 2   NCT00848393   United States;
Fentanyl (Low Dose) + Dexmedetomidine
   Nationwide Children's Hospital
      2008   Phase 2   NCT00848393   United States;
Fluorescite
   Aditya Kaza
      2019   Phase 2   NCT04017975   United States;
HTK cardioplegia
   Ain Shams University
      2021   Early Phase 1   NCT05176782   Egypt;
Ketamine
   Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University
      2016   -   ChiCTR-IOR-16008571   China;
Left ventricular contractile reserve SE
   Fatebenefratelli Hospital
      2016   -   NCT03049995   Italy;
Left ventricular outflow tract gradient SE
   Fatebenefratelli Hospital
      2016   -   NCT03049995   Italy;
Losartan
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2013   Phase 2   NCT02010905   Netherlands;
Mitral regurgitation SE
   Fatebenefratelli Hospital
      2016   -   NCT03049995   Italy;
Physical Exam
   Bernhard Kuhn
      2022   Phase 1   NCT04713657   United States;
Propranolol Hydrochloride
   Bernhard Kuhn
      2022   Phase 1   NCT04713657   United States;
Pulmonary hemodynamics SE
   Fatebenefratelli Hospital
      2016   -   NCT03049995   Italy;
Recombinant human brain natriuretic peptide (rhBNP)
   Shanghai Jiao Tong University School of Medicine
      2013   -   NCT01941576   China;
Sodium citrate
   National Center for Research Resources (NCRR)
      1995   -   NCT00004361   -
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
   Nemours Children's Health System
      2022   Phase 1/Phase 2   NCT05186415   -
TOF repair with trans-annular patch VS preservation of PV
   Assiut University
      2018   -   NCT03732742   -
Thymidine
   Bernhard Kuhn
      2022   Phase 1   NCT04713657   United States;
Tranexamic acid
   National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
      2018   -   ChiCTR1800019578   China;